Henry Schein, Inc. (Nasdaq: HSIC), a supplier of healthcare options to office-based dental and medical practitioners, Monday reported a rise in web revenue for the primary quarter of 2025.
- At $3.2 billion, first-quarter gross sales remained broadly unchanged YoY; gross sales rose 1.4% on a relentless forex foundation
- Web revenue for the quarter elevated to $110 million or $0.88 per share from $93 million or $0.72 per share in Q1 2024
- Adjusted web revenue, excluding particular objects, was $143 million or $1.15 per share in Q1, vs. $143 million or $1.10 per share final yr
- First-quarter adjusted EBITDA got here in at $259 million, in comparison with adjusted EBITDA of $255 million within the year-ago quarter
- Throughout the quarter, the corporate incurred $25 million in restructuring prices; it expects to attain annual run-rate financial savings on the excessive finish of its $75-$100 million aim by the top of 2025
- In Q1, Henry Schein repurchased round 2.3 million shares of its frequent inventory at a median worth of $71.58 per share, for a complete of $161 million
- For fiscal 2025, the administration expects adjusted earnings to be within the vary of $4.80 to $4.94, reflecting a 1-4% development
- It continues to anticipate full-year web gross sales to develop between 2% to 4% in comparison with final yr
